Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease

Journal of Clinical Pathology

Volumn 64, Issue 1, 2011, Pages 16-24

  Mackinnon, Alexander C ^a   Tretiakova, Maria ^a   Henderson, Les ^a   Mehta, Rajendra G ^b   Yan, Benjamin C ^a   Joseph, Loren ^a   Krausz, Thomas ^a   Husain, Aliya N ^a   Reid, Mary E ^c   Salgia, Ravi ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PAXILLIN;

ADULT; ARTICLE; BRONCHOSCOPY; CANCER RISK; CHROMOSOME 12; CODON; COPY NUMBER VARIATION; CORRELATION ANALYSIS; EUSOMY; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE LOCUS; GOBLET CELL METAPLASIA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KRAS GENE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG LAVAGE; LUNG LESION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUTATIONAL ANALYSIS; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; BIOPSY; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; GENE DOSAGE; GENES, ERBB-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PAXILLIN; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 78650807772     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.075853     Document Type: Article

References (33)

1. Midthun DE, Jett JR. Update on screening for lung cancer. Semin Respir Crit Care Med 2008;29:233-40.
2. Henschke CI, Yankelevitz DF. CT screening for lung cancer: update 2007. Oncologist 2008;13:65-78.
3. Arens C, Dreyer T, Malzahn K, et al. Direct and indirect autofluorescence laryngoscopy in the diagnosis of laryngeal cancer and its precursor lesions. Otolaryngol Pol 2004;58:197-203.
4. Chhajed PN, Shibuya K, Hoshino H, et al. A comparison of video and autofluorescence bronchoscopy in patients at high risk of lung cancer. Eur Respir J 2005;25:951-5. (Pubitemid 40823767)
5. Lam B, Wong MP, Fung SL, et al. The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer. Eur Respir J 2006;28:915-19. (Pubitemid 46331958)
6. Lam S, Kennedy T, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998;113:696-702. (Pubitemid 28130944)
7. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006;1:331-48.
8. El-Bayoumi E, Silvestri GA. Bronchoscopy for the diagnosis and staging of lung cancer. Semin Respir Crit Care Med 2008;29:261-70. (Pubitemid 351748432)
9. Jagadeeswaran R, Surawska H, Krishnaswamy S, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res 2008;68:132-42.
10. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87.
11. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev 2004;84:1315-39.
12. Deakin NO, Turner CE. Paxillin comes of age. J Cell Sci 2008;121:2435-44.
13. Sheibani N, Tang Y, Sorenson CM. Paxillin's LD4 motif interacts with bcl-2. J Cell Physiol 2008;214:655-61. (Pubitemid 351224209)
14. Sorenson CM. Interaction of bcl-2 with Paxillin through its BH4 domain is important during ureteric bud branching. J Biol Chem 2004;279:11368-74.
15. Loewen G, Natarajan N, Tan D, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007;62:335-40. (Pubitemid 46580577)
16. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med 1955;12:81-6.
17. Travis WD, Brambilla E, Muller-Hermelink HK, et al. eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press, 2004.
18. Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003;88:2318-26.
19. Greig GM, Parikh S, George J, et al. Molecular cytogenetics of alpha satellite DNA from chromosome 12: fluorescence in situ hybridization and description of DNA and array length polymorphisms. Cytogenet Cell Genet 1991;56:144-8.
20. Sagawa M, Saito Y, Fujimura S, et al. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer 1998;77:720-3. (Pubitemid 28077458)
21. Westra WH, Baas IO, Hruban RH, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996;56:2224-8.
22. Taguchi T, Zhou JY, Feder M, et al. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet 1996;89:120-5.
23. Weir B, Zhao X, Meyerson M. Somatic alterations in the human cancer genome. Cancer Cell 2004;6:433-8.
24. Lantuejoul S, Salameire D, Salon C, et al. Pulmonary preneoplasia- sequential molecular carcinogenetic events. Histopathology 2009;54:43-54.
25. Dacic S. Pulmonary preneoplasia. Arch Pathol Lab Med 2008;132:1073-8.
26. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-56.
27. Lee JJ, Liu D, Lee JS, et al. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst 2001;93:1081-8. (Pubitemid 32717540)
28. Koukouritaki SB, Lianos EA. Glucocorticoid effect on human mesangial cell cytoskeletal proteins. J Lab Clin Med 1999;133:378-83.
29. Koukouritaki SB, Tamizuddin A, Lianos EA. Enhanced expression of the cytoskeleton-associated proteins paxillin and focal adhesion kinase in glomerular immune injury. J Lab Clin Med 1999;134:173-9.
30. Jenq W, Cooper DR, Ramirez G. Integrin expression on cell adhesion function and up-regulation of P125FAK and paxillin in metastatic renal carcinoma cells. Connect Tissue Res 1996;34:161-74. (Pubitemid 127543505)
31. Li HG, Xie DR, Shen XM, et al. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005;11:1445-51.
32. Short SM, Yoder BJ, Tarr SM, et al. The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study. Breast J 2007;13;130-9.
33. Nakanishi K, Kawai T, Kumaki F, et al. Survivin expression in atypical adenomatous hyperplasia of the lung. Am J Clin Pathol 2003;120:712-19.